Roughly half of men in their 50s and around 80 percent of men over 80 develop some degree of prostate enlargement, making it one of the most common conditions in male aging. BPH, short for benign prostatic hyperplasia, is the non-cancerous overgrowth of glandular and stromal tissue inside the prostate that gradually squeezes the urethra. The result is a familiar set of urinary symptoms: weak stream, hesitancy, frequency, and waking up multiple times to pee.
What BPH Is and Isn’t
The prostate sits beneath the bladder, wrapped around the urethra like a doughnut. As men age, hormonal shifts driven largely by dihydrotestosterone (DHT) prompt cells in the transitional zone to multiply. The gland gets bigger, and that bulk pushes inward against the urethra. Per the NIDDK, an enlarged prostate does not turn into cancer and does not raise the risk of prostate cancer. They are different conditions that happen to affect the same organ.
That distinction is important because the workup for urinary symptoms in older men routinely uncovers both. Many patients arrive worried about cancer and leave with a benign hyperplasia diagnosis, while others end up needing both monitored.
Symptoms and the IPSS Score
Urologists group BPH symptoms into storage and voiding categories. Storage symptoms include urgency, frequency (more than every two hours during the day), and nocturia, the medical term for nighttime urination. Voiding symptoms include hesitancy, weak or intermittent stream, dribbling at the end of urination, and a sense of incomplete emptying. Many men also notice they suddenly need to bear down to start the stream.
The American Urological Association uses the International Prostate Symptom Score (IPSS), a seven-question form scored 0 to 35. Scores of 0 to 7 are mild, 8 to 19 are moderate, and 20 to 35 are severe. The questionnaire helps quantify symptoms and track response to treatment.
Causes and Risk Factors
Age is the dominant factor. By age 60, more than half of men have histologic evidence of BPH on biopsy or autopsy, and that share keeps climbing. Family history matters too. Men whose fathers or brothers needed BPH treatment have higher odds of needing it themselves, especially when symptoms appear before age 60. Obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease are all linked to faster prostate growth and worse symptoms, possibly through chronic low-grade inflammation and hormonal effects.
Race plays a role as well. Mayo Clinic research suggests men of African descent often experience earlier and more severe symptoms, while certain Asian populations historically reported lower rates, though those gaps narrow as diets change.
How BPH Is Diagnosed
A primary care or urology visit usually starts with the IPSS, a focused history, and a digital rectal exam (DRE) to estimate prostate size and texture. A PSA blood test is often added because BPH can elevate PSA, and any concerning result prompts further evaluation. For more on PSA interpretation, the PSA test guide walks through reference ranges, density, and velocity.
A urinalysis rules out infection or microscopic blood. Some clinicians order a post-void residual (PVR) ultrasound to measure how much urine remains in the bladder after urination. A PVR over 100 to 150 mL suggests poor emptying. Uroflowmetry measures stream speed, with peak flows under 10 mL per second considered abnormal. Cystoscopy and transrectal ultrasound are reserved for selected cases. Prostatitis can mimic BPH symptoms and is part of the differential, particularly in younger men.
Treatment Options
Mild symptoms with low IPSS scores often need nothing beyond watchful waiting and lifestyle adjustments: limiting fluids before bed, cutting caffeine and alcohol, and double-voiding to empty more completely. Pelvic floor exercises help some men with mixed symptoms.
Medications
Alpha blockers such as tamsulosin, alfuzosin, and silodosin relax smooth muscle in the prostate and bladder neck, easing flow within days. They do not shrink the gland. 5-alpha reductase inhibitors (5-ARIs) like finasteride and dutasteride block the conversion of testosterone to DHT, gradually reducing prostate volume by 20 to 30 percent over 6 to 12 months. Combination therapy outperforms monotherapy in men with larger glands, as the landmark MTOPS and CombAT trials demonstrated. Phosphodiesterase-5 inhibitors like daily tadalafil 5 mg are FDA-approved for BPH and are particularly useful when erectile dysfunction coexists. Anticholinergics or beta-3 agonists such as mirabegron may be added for storage-predominant symptoms.
Procedures and Surgery
When medication fails or complications develop, several procedural options exist. Transurethral resection of the prostate (TURP) remains the historical benchmark, though newer minimally invasive techniques are rapidly displacing it. UroLift uses small implants to retract obstructing tissue without cutting. Rezum delivers steam to ablate prostate tissue. Holmium laser enucleation (HoLEP) and aquablation are options for larger glands. Prostatic artery embolization (PAE) is performed by interventional radiologists. Each approach has trade-offs in recovery time, sexual side effects, and durability, which a urologist can walk through.
When to See a Doctor
Bothersome urinary symptoms, blood in the urine, recurrent urinary tract infections, sudden inability to urinate, or significant disruption of sleep due to nocturia all warrant medical evaluation. Untreated severe BPH can lead to bladder damage, kidney injury, and chronic retention.
When to seek emergency care: Call 911 or go to the nearest emergency room if you experience complete inability to urinate (acute urinary retention), severe lower abdominal pain with a distended bladder, blood clots in the urine causing obstruction, or fever above 101 degrees Fahrenheit with urinary symptoms suggesting urosepsis.
Frequently Asked Questions
Does BPH increase the risk of prostate cancer?
No. BPH and prostate cancer arise in different zones of the gland and through different mechanisms. Having an enlarged prostate does not raise cancer risk, although both conditions become more common with age and may be diagnosed in the same patient.
How long do BPH medications take to work?
Alpha blockers usually produce noticeable improvement within a few days to two weeks. 5-alpha reductase inhibitors work more slowly because they shrink the gland, with peak benefit at 6 to 12 months.
Can BPH cause erectile dysfunction?
BPH itself does not directly cause ED, but the two conditions share risk factors and often coexist. Some BPH medications, particularly 5-ARIs, can lower libido and cause erectile side effects in a minority of men.
Is BPH surgery permanent?
Most surgical and minimally invasive procedures provide durable symptom relief for 5 to 15 years, depending on the technique. Some men eventually need a second procedure as the prostate continues to grow.
What to Do Next
If urinary symptoms are interfering with sleep or daily life, the first step is a primary care visit with an IPSS, urinalysis, and PSA. From there, treatment is genuinely individualized: small glands with mild symptoms may need only lifestyle changes, while larger glands or worse symptoms typically respond to medication, with procedures available when drugs fall short. The current generation of minimally invasive options has changed the calculus significantly, so men who were told a decade ago that surgery was the only answer may have better choices today.